Laura Do Souto Ferreira

Nantes, France

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications

Unveiling the immune microenvironment in sinonasal intestinal type adenocarcinoma: new arguments for immunotherapy.

Unveiling the immune microenvironment in sinonasal intestinal type adenocarcinoma: new arguments for immunotherapy.

Journal: Oncoimmunology
Published: September 03, 2026

De novo variants in the splicing factor gene SF3B1 are associated with neurodevelopmental disorders.

De novo variants in the splicing factor gene SF3B1 are associated with neurodevelopmental disorders.

Journal: Nature communications
Published: December 18, 2024

Heterozygous alterations of GTF2I at the Williams-Beuren syndrome's locus cause a neurodevelopmental disorder.

Heterozygous alterations of GTF2I at the Williams-Beuren syndrome's locus cause a neurodevelopmental disorder.

Journal: Journal of medical genetics
Published: November 05, 2024

Dominant variants in major spliceosome U4 and U5 small nuclear RNA genes cause neurodevelopmental disorders through splicing disruption.

Dominant variants in major spliceosome U4 and U5 small nuclear RNA genes cause neurodevelopmental disorders through splicing disruption.

Journal: Nature genetics
Published: October 02, 2024

Randall-Type Monoclonal IgE Kappa Light-Heavy Chain Deposition Disease.

Randall-Type Monoclonal IgE Kappa Light-Heavy Chain Deposition Disease.

Journal: Kidney international reports
Published: January 09, 2023

Biallelic deletion of 1p32 defines ultra-high-risk myeloma, but monoallelic del(1p32) remains a strong prognostic factor.

Biallelic deletion of 1p32 defines ultra-high-risk myeloma, but monoallelic del(1p32) remains a strong prognostic factor.

Journal: Blood
Published: July 21, 2022

Primary plasma cell leukemias displaying t(11;14) have specific genomic, transcriptional, and clinical features.

Primary plasma cell leukemias displaying t(11;14) have specific genomic, transcriptional, and clinical features.

Journal: Blood
Published: December 09, 2021

Toll-like receptor 4 selective inhibition in medullar microenvironment alters multiple myeloma cell growth.

Toll-like receptor 4 selective inhibition in medullar microenvironment alters multiple myeloma cell growth.

Journal: Blood advances
Published: October 28, 2020
Showing 1-8 of 8

Last Updated: 09/26/2026